# Towards Optimal Prescription of Chemotherapy in Prostate Cancer

> **NCT02512185** · — · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 206 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02512185
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-12-31
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2020-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02512185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02512185, "Towards Optimal Prescription of Chemotherapy in Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02512185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*